Overall, our molecular assays demonstrated that HMN-214 inhibits the PLK1 signaling cascade and important cell cycle regulators at both mRNA and protein levels to block NB cell cycle progression (Figure 5) and to overall inhibit NB growth (Figure 1, Figure 2, Figure 6 and Figure 7). The gene discussed is PLK1; the disease is neuroblastoma.